|
|
Volumn 86, Issue 2, 2008, Pages 291-292
|
|
Concurrent radiation therapy and bortezomib in myeloma patient
a
a
a
a
a
INSTITUT CURIE
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
DEXAMETHASONE;
DOXORUBICIN;
MELPHALAN;
THALIDOMIDE;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
BORONIC ACID DERIVATIVE;
PYRAZINE DERIVATIVE;
ADULT;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RADIOTHERAPY;
CANCER STAGING;
CASE REPORT;
HUMAN;
LETTER;
MALE;
MYELOMA;
PRIORITY JOURNAL;
SENSITIVITY ANALYSIS;
TREATMENT RESPONSE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
MULTIPLE MYELOMA;
RADIATION DOSE;
RADIATION DOSE FRACTIONATION;
ANTINEOPLASTIC AGENTS;
BORONIC ACIDS;
COMBINED MODALITY THERAPY;
DOSE FRACTIONATION;
HUMANS;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
PYRAZINES;
RADIOTHERAPY DOSAGE;
|
|
EID: 39149122818
PISSN: 01678140
EISSN: None
Source Type: Journal
DOI: 10.1016/j.radonc.2007.12.015 Document Type: Letter |
|
Times cited : (12)
|
|
References (5)
|
